van Setten P A, van Hinsbergh V W, van der Velden T J, van de Kar N C, Vermeer M, Mahan J D, Assmann K J, van den Heuvel L P, Monnens L A
Department of Pediatrics, University Hospital, Nijmegen, The Netherlands.
Kidney Int. 1997 Apr;51(4):1245-56. doi: 10.1038/ki.1997.170.
In the pathogenesis of the hemolytic uremic syndrome (HUS), endothelial damage of glomeruli and arterioles of the kidney appears to play a central role. Previous studies have shown that verocytotoxin-1 (VT-1) cytotoxicity on human vein endothelial cells require additional stimuli, in particular the inflammatory mediator tumor necrosis factor alpha (TNF alpha). In this study the effects of VT on human glomerular microvascular endothelial cells (GMVEC) were examined. A reproducible method was developed for the isolation and purification of large numbers of highly purified GMVEC. The obtained GMVEC were over 99% pure; their endothelial origin was demonstrated by the expression of the endothelial antigens von Willebrand factor, EN-4, PECAM-1 and V,E-cadherin. Upon stimulation with TNF alpha the cells expressed the endothelial-specific adhesion molecule E-selectin. A limited number of fenestral structures was observed by scanning electron microscopy (SEM), suggesting glomerular origin of the endothelial cells. Cytotoxicity of VT-1 to GMVEC was evaluated by determination of the number of viable adherent cells and by assay of overall protein synthesis after exposure to varying concentrations of VT-1. In non-stimulated GMVEC, cytotoxicity of VT-1 was inversely related to the degree and duration of confluence, subconfluent cells being the most sensitive. In highly confluent GMVEC, VT cytotoxicity required pre-exposure of the cells to the inflammatory mediator TNF alpha, which induced an increase in the number of VT receptors on GMVEC. Thin layer chromatography of extracted glycolipids from the GMVEC showed binding of VT-1 to globotriaosylceramide (Gb3), known to be the functional receptor for VT. There were no major differences in protein synthesis inhibition with equal concentrations VT-1 and VT-2. In conclusion, in this study we provide a reproducible method to isolate, purify and culture well characterized human GMVEC on a routine basis. In vitro studies with these GMVEC demonstrate that VT cytotoxicity depends on the degree of confluence and the additional preexposure to the inflammatory mediator TNF alpha. These observations provide further insight into the complex events that may occur in glomeruli in the pathogenesis of HUS.
在溶血性尿毒症综合征(HUS)的发病机制中,肾脏肾小球和小动脉的内皮损伤似乎起着核心作用。先前的研究表明,志贺毒素-1(VT-1)对人静脉内皮细胞的细胞毒性需要额外的刺激,特别是炎症介质肿瘤坏死因子α(TNFα)。在本研究中,检测了VT对人肾小球微血管内皮细胞(GMVEC)的影响。开发了一种可重复的方法来分离和纯化大量高度纯化的GMVEC。所获得的GMVEC纯度超过99%;通过内皮抗原血管性血友病因子、EN-4、血小板内皮细胞黏附分子-1(PECAM-1)和V,E-钙黏蛋白的表达证明了它们的内皮来源。在用TNFα刺激后,细胞表达内皮特异性黏附分子E-选择素。通过扫描电子显微镜(SEM)观察到有限数量的窗孔结构,提示内皮细胞来源于肾小球。通过测定活贴壁细胞数量和在暴露于不同浓度的VT-1后检测总蛋白合成来评估VT-1对GMVEC的细胞毒性。在未刺激的GMVEC中,VT-1的细胞毒性与汇合程度和持续时间呈负相关,亚汇合细胞最敏感。在高度汇合的GMVEC中,VT细胞毒性需要细胞预先暴露于炎症介质TNFα,这会导致GMVEC上VT受体数量增加。从GMVEC中提取的糖脂的薄层色谱显示VT-1与球三糖基神经酰胺(Gb3)结合,已知Gb3是VT的功能性受体。相同浓度的VT-1和VT-2在抑制蛋白合成方面没有主要差异。总之,在本研究中,我们提供了一种可重复的方法,用于常规分离、纯化和培养特征明确的人GMVEC。对这些GMVEC的体外研究表明,VT细胞毒性取决于汇合程度以及预先暴露于炎症介质TNFα。这些观察结果为HUS发病机制中肾小球可能发生的复杂事件提供了进一步的见解。